Home › Hyperthyroidism › Texas › Dallas
Hyperthyroidism clinical trials in Dallas, TX
5 studies for Hyperthyroidism are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
- Site-055, Dallas
- Site-020, Dallas
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
RecruitingPhase 2
- M3 Wake Research - Dallas, Dallas
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
RecruitingPhase 2
- Site 133, Dallas
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1019, Dallas
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-109, Dallas
About Hyperthyroidism
Thyroid hormones control the rate of many activities in your body. Hyperthyroidism means the thyroid makes more thyroid hormones than the body needs.
More about Hyperthyroidism on MedlinePlus
Hyperthyroidism trials in other cities
- Houston, TX5 studies
- Miami, FL5 studies
- Washington, DC3 studies
- Hialeah, FL3 studies
- Asheville, NC3 studies
- Wilmington, NC3 studies
- Akron, OH3 studies
- San Antonio, TX3 studies
- San Francisco, CA3 studies
- Torrance, CA3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.